<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04571047</url>
  </required_header>
  <id_info>
    <org_study_id>Tidop</org_study_id>
    <nct_id>NCT04571047</nct_id>
  </id_info>
  <brief_title>Time to Surgery - the Impact of Waiting Time on Outcome After Colorectal Cancer Treatment</brief_title>
  <acronym>Tidop</acronym>
  <official_title>Time to Surgery - the Impact of Waiting Time on Outcome After Colorectal Cancer Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sahlgrenska University Hospital, Sweden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We aim to perform a register-based, observational cohort study to investigate whether it is&#xD;
      safe to delay start of treatment with a curative intention after a colorectal cancer&#xD;
      diagnosis. Our hypothesis is that delaying start of treatment until 4-8 weeks is as safe as&#xD;
      starting treatment within four weeks after a colorectal cancer diagnosis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 15, 2020</start_date>
  <completion_date type="Anticipated">August 15, 2021</completion_date>
  <primary_completion_date type="Actual">July 15, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Overall survival</measure>
    <time_frame>3 years</time_frame>
    <description>Overall survival</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>90 days</time_frame>
    <description>Hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Re-operations within 3 months</measure>
    <time_frame>90 days</time_frame>
    <description>Surgical procedures registered within 3 months after the procedure date</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Re-admissions within 3 months</measure>
    <time_frame>90 days</time_frame>
    <description>Readmissions registered within 3 months after the procedure date</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radical surgery</measure>
    <time_frame>90 days</time_frame>
    <description>Defined as R0 resection</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40000</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Colorectal cancer patients</arm_group_label>
    <description>Patients diagnosed with colonrectal cancer between 2008-2016</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Time to treatment</intervention_name>
    <description>Treatment before or after 4 weeks after diagnosis</description>
    <arm_group_label>Colorectal cancer patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients registered with a diagnosis of colorectal cancer in Sweden between 2008-2016&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosed with colorectal cancer 2008-2016 in Sweden&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eva Angenete</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sahlgrenska Universitetssjukhuset</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eva Angenete, MD. PhD</last_name>
    <phone>+46760514441</phone>
    <email>eva.angenete@vgregion.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aron Onerup, MD</last_name>
    <email>aron.onerup@gu.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital</name>
      <address>
        <city>GÃ¶teborg</city>
        <zip>41132</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eva Angenete</last_name>
      <phone>0760514441</phone>
      <email>eva.angenete@vgregion.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>September 2, 2020</study_first_submitted>
  <study_first_submitted_qc>September 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2020</study_first_posted>
  <last_update_submitted>July 15, 2021</last_update_submitted>
  <last_update_submitted_qc>July 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sahlgrenska University Hospital, Sweden</investigator_affiliation>
    <investigator_full_name>Eva Angenete</investigator_full_name>
    <investigator_title>Professor of surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>The data is extracted from CRCBaSe, (ColoRectal Cancer Data Base) a combination of several registries in Sweden and thus the sharing option will be decided by that work group</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

